市值: $2.7405T -3.520%
體積(24小時): $54.496B -46.820%
  • 市值: $2.7405T -3.520%
  • 體積(24小時): $54.496B -46.820%
  • 恐懼與貪婪指數:
  • 市值: $2.7405T -3.520%
Cryptos
主題
Cryptospedia
資訊
CryptosTopics
影片
Top News
Cryptos
主題
Cryptospedia
資訊
CryptosTopics
影片
bitcoin
bitcoin

$85715.775692 USD

-0.35%

ethereum
ethereum

$2168.673546 USD

1.84%

tether
tether

$0.999884 USD

0.00%

xrp
xrp

$2.311746 USD

-0.73%

bnb
bnb

$583.962479 USD

-1.99%

solana
solana

$138.385846 USD

0.31%

usd-coin
usd-coin

$0.999955 USD

0.00%

cardano
cardano

$0.805589 USD

-0.44%

dogecoin
dogecoin

$0.188680 USD

-3.13%

tron
tron

$0.241022 USD

-3.63%

pi
pi

$1.538715 USD

-14.57%

chainlink
chainlink

$14.993939 USD

-2.02%

hedera
hedera

$0.220210 USD

-3.19%

unus-sed-leo
unus-sed-leo

$9.755176 USD

-0.84%

stellar
stellar

$0.277335 USD

0.39%

加密貨幣新聞文章

生物協議:分散科學(DESCI)運動正在迅速改變研究

2025/02/28 01:00

分散的科學(DESCI)運動正在迅速改變生物技術的研究,創新和資金。 BIO協議是一個由Binance Labs支持的項目,正在領導這一轉變。

生物協議:分散科學(DESCI)運動正在迅速改變研究

The decentralized science (DeSci) movement is quickly changing how research, innovation, and funding work in biotech, especially with Binance Labs-backed protocol BIO Protocol leading the way.

分散的科學(DESCI)運動正在迅速改變生物技術的研究,創新和資金工作,尤其是在Binance Labs支持的協議BIO協議中,領先的。

According to CoinGecko report, the protocol uses blockchain technology to create a decentralized space where researchers, biotech professionals, and patients can come together to fund projects, control intellectual property (IP), and collectively decide on the direction of biotechnological advancements.

根據Coingecko報告,該協議使用區塊鏈技術創建一個分散的空間,研究人員,生物技術專業人員和患者可以聚集在一起資助項目,控制知識產權(IP),並共同決定生物技術進步的方向。

Breaking Down Traditional Research Barriers

打破傳統的研究障礙

This new approach solves problems in traditional scientific research, such as limited access, stalled funding, and opaque peer-review systems. The increasing footprint of DeSci was evident in the 2,640% surge in sector growth between January and December 2024, showcasing its potential to disrupt the industry.

這種新方法解決了傳統科學研究的問題,例如有限的訪問,停滯的資金和不透明的同行評審系統。在2024年1月至1224年12月之間,Desci的佔地面積的增加在2,640%的行業增長中顯而易見,這表明了其破壞該行業的潛力。

Among the protocols spearheading this shift, BIO Protocol stands out as a major force. It's known for its community-driven initiatives like BioDAOs, tokenized governance, and liquidity tools that are fuelling sustainable biotech progress.

在帶頭轉變的協議中,生物協議是主要力量。它以其社區驅動的計劃,例如生物紀念品,令牌化治理和流動性工具而聞名,這些工具正在推動可持續生物技術的進步。

DeSci: A New Model for Research

DESCI:一種新的研究模型

Scientific research has long been controlled by centralized institutions. Universities, publishers, and funding bodies have historically held the reins of scientific endeavors. While these institutions have supported groundbreaking discoveries, they've also created barriers.

長期以來,科學研究一直由集中的機構控制。從歷史上看,大學,出版商和資助機構一直持有科學努力。儘管這些機構支持了開創性的發現,但它們也創造了障礙。

This includes limited access to opportunities, slow or stalled funding, and high costs that burden researchers. DeSci presents a different model. It leverages blockchain to build an open and transparent space for research.

這包括有限的機會機會,緩慢或停滯的資金以及負擔重大的研究人員。 Desci提出了不同的模型。它利用區塊鏈建立開放透明的研究空間。

This new model encourages scientists to collaborate globally, apply for funding directly, and share their findings without restrictions.

這個新模型鼓勵科學家在全球範圍內進行合作,直接申請資金,並在毫不限制的情況下分享他們的發現。

Crypto Leaders Back DeSci Vision

加密領導者回到desci願景

Key figures in the blockchain industry, like Ethereum's Vitalik Buterin and Binance's Changpeng Zhao, have expressed optimism toward DeSci. In 2024, the growth of DeSci protocols was evident, with the top five projects, including BIO Protocol, reaching a combined market cap of over $2.3 billion in January 2025.

區塊鏈行業的關鍵人物,例如以太坊的Vitalik Buterin和Binance的Changpeng Zhao,對Desci表示樂觀。 2024年,DESCI協議的增長很明顯,其中包括生物協議在內的前五名項目在2025年1月的綜合市值超過23億美元。

This collective footprint showcases the increasing interest in decentralized scientific collaboration and funding models.

這種集體足跡展示了對分散的科學合作和資助模型的興趣日益增加。

BIO Protocol's Key Features

生物協議的關鍵特徵

BIO Protocol is designed to streamline biotech research using decentralized financial models and governance. One of its main innovations is the creation of BioDAOs. These are community-driven research networks that collect funds through token sales to support biotech projects.

BIO協議旨在使用分散的財務模型和治理來簡化生物技術研究。它的主要創新之一是生物的創造。這些是社區驅動的研究網絡,通過令牌銷售收集資金以支持生物技術項目。

IP ownership is shared among members, and the BioDAOs reinvest earnings back into research and development, forming a continuous funding cycle.

IP所有權在成員之間共享,而Biodaos將收入重新投資回到研發中,形成了一個持續的資金周期。

Rewarding Contributions and Decentralized Governance

獎勵貢獻和分散的治理

Another key aspect is the Bio/Acc rewards system, which incentivizes contributors, researchers, and token holders. Approximately 133 million BIO tokens, making up 4% of the total supply, have been allocated to reward active participation in the ecosystem.

另一個關鍵方面是生物/ACC獎勵系統,它激勵貢獻者,研究人員和代幣持有人。大約有1.33億個生物令牌佔總供應的4%,已分配以獎勵積極參與生態系統。

Moreover, the protocol's curation system enables BIO token holders to vote on which projects should be funded, ensuring decentralized decision-making and fair distribution of resources.

此外,該協議的策展系統使生物令牌持有人能夠對哪些項目進行投票,以確保分散的決策和資源的公平分配。

BIO Protocol also introduces Intellectual Property Tokens (IPTs), which enable fractional ownership of biotech research and innovations. These tokens grant holders governance rights and access to exclusive project updates, fostering transparency and engagement within the research community.

生物協議還引入了知識產權令牌(IPTS),該標記可以使生物技術研究和創新的分數所有權。這些令牌授予持有人的治理權利和獲得獨家項目更新的訪問權限,從而促進了研究社區內的透明度和參與度。

Real-World Applications and Future Potential

現實世界的應用和未來潛力

One of the most pressing issues faced by the scientific community is the reproducibility of published papers. Nearly 50% of published studies fail replication tests, highlighting a critical flaw in traditional scientific reporting.

科學界面臨的最緊迫的問題之一是發表論文的可重複性。近50%的已發表研究失敗了複製測試,強調了傳統科學報告中的關鍵缺陷。

To tackle this, BIO Protocol's architecture allows for the auditing of scientific papers using blockchain and artificial intelligence. This capability becomes particularly relevant in light of the reproducibility crisis affecting scientific papers.

為了解決這個問題,生物協議的體系結構允許使用區塊鍊和人工智能審核科學論文。鑑於影響科學論文的可重複性危機,這種能力尤其重要。

In addition, the protocol supports public goods that traditional institutions often miss, such as scaling scientific validation efforts. Traditional funding models typically prioritize projects that promise swift financial returns.

此外,該協議支持傳統機構經常錯過的公共物品,例如擴展科學驗證工作。傳統資金模型通常會優先考慮承諾迅速財務回報的項目。

In contrast, BIO Protocol's structure, with its decentralized and community-based funding, empowers researchers to pursue groundbreaking research that benefits society. This structure encourages innovation by researchers who aren't limited by financial constraints.

相比之下,生物協議的結構憑藉其分散和基於社區的資金,使研究人員有能力從事有益於社會的開創性研究。這種結構鼓勵不受財務限制的研究人員的創新。

New Funding Models for Researchers

研究人員的新資金模型

Unlike traditional financial systems that demand strict investor terms, BIO Protocol's tokenized funding model offers capital without equity dilution or rigid repayment schedules.

與需要嚴格投資者條款的傳統金融系統不同,Bio Protopity的令牌資金模型提供了資本,而無需公平稀釋或嚴格的還款時間表。

Researchers can obtain funding through community engagement and token-based incentives, enabling them to work on high-impact projects without facing pressure to conform to predefined financial metrics.

研究人員可以通過社區參與和基於令牌的激勵措施獲得資金,使他們能夠從事高影響力項目,而無需面對符合預定義的金融指標的壓力。

Related: BIO Protocol Expands to Solana: What This Means for DeSci

相關:生物協議擴展到Solana:這對Desci意味著什麼

BIO Token and Its Utility

生物令牌及其實用程序

The BIO token serves as the governance and utility token within the BIO Protocol ecosystem. Token holders participate in decision-making, vote on fund allocations, and gain access to accelerator programs that support biotech innovations. They also receive special benefits, such as whitelist opportunities in BioDAO funding rounds and potential rewards for contributions to clinical trials and research.

生物代幣在生物協議生態系統中充當治理和實用程序。令牌持有人參與決策,對資金分配進行投票,並獲得支持生物技術創新的加速器計劃。他們還獲得了特殊的好處,例如Biodao資助回合中的白名單機會,以及潛在的臨床試驗和研究貢獻的獎勵。

The total supply of BIO tokens is set at 3.32 billion and has a dynamic system that allows for adjustments through governance. At launch, 56% of the tokens were allocated for community initiatives, while the remaining 44% were distributed among early contributors,

生物代幣的總供應設定為33.2億,並且具有動態系統,可以通過治理進行調整。發佈時,將56%的代幣分配給社區倡議,而其餘的44%則分配給早期貢獻者,

免責聲明:info@kdj.com

所提供的資訊並非交易建議。 kDJ.com對任何基於本文提供的資訊進行的投資不承擔任何責任。加密貨幣波動性較大,建議您充分研究後謹慎投資!

如果您認為本網站使用的內容侵犯了您的版權,請立即聯絡我們(info@kdj.com),我們將及時刪除。

2025年03月09日 其他文章發表於